BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24288198)

  • 1. Cytoplasmic PML: from molecular regulation to biological functions.
    Jin G; Gao Y; Lin HK
    J Cell Biochem; 2014 May; 115(5):812-8. PubMed ID: 24288198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.
    Shimada N; Shinagawa T; Ishii S
    Genes Cells; 2008 Mar; 13(3):245-54. PubMed ID: 18298799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Cellular Functions of Cytoplasmic PML.
    Jin G; Wang YJ; Lin HK
    Front Oncol; 2013; 3():147. PubMed ID: 23761861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
    Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
    J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress in cytoplasmic PML gene functions].
    Xu XH; Sun YY; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):857-60. PubMed ID: 24989309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
    Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
    Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cytoplasmic PML mutant inhibits p53 function.
    Bellodi C; Kindle K; Bernassola F; Cossarizza A; Dinsdale D; Melino G; Heery D; Salomoni P
    Cell Cycle; 2006 Nov; 5(22):2688-92. PubMed ID: 17172828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
    Reineke EL; Kao HY
    Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
    Condemine W; Takahashi Y; Le Bras M; de Thé H
    J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional proteomic analysis of promyelocytic leukaemia nuclear bodies in irradiation-induced MCF-7 cells.
    Liu J; Song Y; Tian B; Qian J; Dong Y; Liu J; Liu B; Sun Z
    J Biochem; 2010 Dec; 148(6):659-67. PubMed ID: 20823370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
    J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML nuclear bodies as sites of epigenetic regulation.
    Torok D; Ching RW; Bazett-Jones DP
    Front Biosci (Landmark Ed); 2009 Jan; 14(4):1325-36. PubMed ID: 19273133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML control of cytokine signaling.
    Maarifi G; Chelbi-Alix MK; Nisole S
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):551-61. PubMed ID: 24861946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
    Salsman J; Wang X; Frappier L
    Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
    Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
    Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.